GD is known to result from an immune disorder in which the patient’s immunoglobulins bind to thyroid-stimulating hormone receptors, causing hyperthyroidism, promoting tumor formation, causing angiogenesis [40,47], upregulating various growth factors, and enhancing tumor invasiveness [12,48]. This evidence concerns the gene TSHR and neoplasm.